The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase Ib study of BI 836880, a VEGF/Ang2-blocking nanobody, in combination with BI 754091, an anti-PD-1 antibody: Initial results in patients (pts) with advanced non-small cell lung cancer (NSCLC).
 
Nicolas Girard
Consulting or Advisory Role - Abbvie; AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; GlaxoSmithKline; Lilly; MSD; Novartis; Pfizer; Pharmamar; Roche; Takeda
Research Funding - AstraZeneca (Inst); Boehringer Ingelheim (Inst); Roche (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Bristol-Myers Squibb; Bristol-Myers Squibb; MSD Oncology; Roche
 
Martin Wermke
Honoraria - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Kite, a Gilead company; Merck; Novartis; Roche
Consulting or Advisory Role - Boehringer Ingelheim; Bristol-Myers Squibb; Heidelberg Pharma; Kite, a Gilead company; Novartis; Roche
Travel, Accommodations, Expenses - AstraZeneca; Bristol-Myers Squibb; Glenmark
 
Fabrice Barlesi
Honoraria - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Lilly; Merck Serono; MSD Oncology; Novartis; Pfizer; Pierre Fabre; Roche; Takeda
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Lilly; Merck; MSD Oncology; Novartis; Pfizer; Pierre Fabre; Roche; Takeda
Research Funding - Abbvie (Inst); ACEA Biosciences (Inst); Amgen (Inst); AstraZeneca (Inst); Bayer (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Eisai (Inst); Lilly (Inst)
 
Harald Timotheus Landsteiner
Employment - Boehringer Ingelheim
 
Girish Jayadeva
Employment - Boehringer Ingelheim
 
Juergen Alt
Honoraria - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; MSD; Novartis; Pfizer; Roche; Takeda
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; MSD; Novartis; Pfizer; Roche; Takeda
 
Björn Hackanson
Honoraria - Boehringer Ingelheim; Bristol-Myers Squibb; MSD
Consulting or Advisory Role - Boehringer Ingelheim; Bristol-Myers Squibb; MSD
Travel, Accommodations, Expenses - Novartis